USPTO serial 77271537
LUBRAMINE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- FRYE, KIMBERLY
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with LUBRAMINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Croydon Surrey, GB
Croydon Surrey, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bill Hudson
Bill Hudson Goldshield Healthcare Direct1501 Northpoint ParkwaySuite 100West Palm Beach, FL 33407Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Adhesives for dentistry and dental technical purposes; All purpose disinfecting and deodorizing preparations; Alloys of precious metal for use in dentistry and dentistry technology; Anesthetics for surgical and non-surgical use; Anti-arthritic compositions and preparations; Anti-inflammatory and antipyretic preparations; Antibacterial/antimicrobial tape for the purpose of destroying bacteria, mold and mildew; Antimicrobial coatings to treat the growth of mold, mildew, bacteria and fungus on various surfaces; Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; Antimicrobial preservatives for cosmetics and pharmaceuticals; Bacterial and bacteriological preparations for medical or veterinary purposes; Bacteriostats for medicinal, dental and veterinary use; Base metals and alloys for dentistry use; Biological and chemical preparations and reagents for medical or veterinary use; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Biscuits, bread, bread rolls, cakes, cereal products, confectionery, crackers, noodles, fish sauce, relish, sauces, cereal-based snack-foods and prepared dietary items that are gluten-free to accommodate special medical and health conditions; Bonding and primer materials for dental purposes; Carpet fresheners and odor eliminators; Cedar wood for use as a clothing protector and/or deodorizer; Composite materials for dental and dental technical purposes; Corn and callus creams; Dental resin for temporary bridges, crowns and veneers; Deodorizing products, namely, all purpose deodorizer preparations for household, commercial and industrial use; Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical and veterinary use; Diagnostic reagents and contrast media for medical use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Dietary and nutritional supplements; Dietary and nutritionally fortified food products adapted for medical use; Dissolvable strips to stop bleeding from minor cuts and grazes; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Embedding material for dental and dental technical purposes; Eye pillows containing aromatic substances for relief from headaches, insomnia and sinus discomfort; Fish, pickles, preserved olives and dietary foods and food-items that are gluten-free to accommodate special medical and health conditions; Fissure sealant for dental and dental technical purposes; Fluid for the topical fluoridation of tooth enamel and decay prevention; Gases for medical and dental use; Germicides and fungicides; Gluten-free food to accommodate special medical and health conditions; Herbal anti-itch and sore skin ointment for pets; Herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; Herbicides, insecticides, pesticides and fungicides for home, garden and lawn use and for professional use; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Material for repairing teeth and for dental crowns and bridges; Material for tooth crowns and tooth bridges for dental and dental technical purposes; Materials for crowns and bridges for dental use and for oral prophylaxis; Materials for dental fillings and for sealing purposes; Meal replacement and dietary supplement drink mixes; Medical cleansers for skin and wounds; Medical diagnostic reagents and assays for testing of body fluids; Medicated diaper rash ointments and lotions; Medicated mouth care and treatment preparations; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicinal preparations for the mouth and as sprays; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Microbiocides for industrial and institutional manufacturing processes and wastewater applications; Mold inhibitors for treating mold growth in and around buildings; Multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; Nasal and oral spray preparations for use as central nervous system stimulants; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; for the treatment of bacteria-based diseases; for the treatment of diabetes, anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Plant extracts for medical, veterinary and pharmaceutical purposes; Precious metals and precious metal alloys for dentistry use; Preparations to prevent nail-biting and thumb-sucking; Products and preparations for cleansing the skin for medical use; Protein reduced and gluten free food for medical purposes; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Reagents and media for medical and veterinary diagnostic purposes; Rubbing compound for medical and/or therapeutic use; Sanitizers for use in institutional and industrial areas; Sinus pillows containing aromatic substances for relief from headaches, insomnia and sinus discomfort; Soy protein for use as a nutritional ingredient in various powdered and ready-to-drink beverages; Strip used to anesthetize the superficial layers of the cornea and also containing preparations to diagnose defects therein using a staining dye; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Thyroid and para-thyroid hormone preparations; Vitamin and mineral formed and packaged as bars; Vitamin and mineral preparations for medical use; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Vitamin and mineral supplements | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 14, 2009 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 14, 2009 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 13, 2008 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 12, 2008 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 10, 2008 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 10, 2008 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 12, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 7, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 20, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 16, 2008 | UNDN | UNDELIVERABLE MAIL - NO ACTION TAKEN | — |
| Apr 30, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 12, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 12, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 25, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 25, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 25, 2008 | ALIE | ASSIGNED TO LIE | — |
| Mar 12, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 31, 2008 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 31, 2008 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 31, 2008 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 2, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 2, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 2, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 12, 2007 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 12, 2007 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 12, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 8, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 10, 2007 | NWAP | NEW APPLICATION ENTERED | — |